Jun 3, 2022 06:59AM
Jun 3, 2022 06:59AM
May 26, 2022 04:30PM
Nov 8, 2021 04:01PM
Jun 1, 2021 09:00AM
Jun 1, 2021 09:00AM
Jan 29, 2021 10:55AM Turning Point Therapeutics Inc. (TPTX) PT Raised to $165 at Goldman Sachs, Following Clinical Trial Update
Jan 13, 2021 03:04AM
Oct 29, 2020 04:15PM
Oct 29, 2020 04:15PM
Oct 27, 2020 05:40AM
Oct 26, 2020 11:33PM
Oct 26, 2020 11:33PM
Oct 26, 2020 07:00AM Turning Point Therapeutics Inc. (TPTX) Announces Commencement of $400M Public Offering of Common Stock
Oct 26, 2020 07:00AM
Oct 26, 2020 07:00AM
Jun 1, 2020 09:00AM
Jun 1, 2020 09:00AM
May 27, 2020 08:30AM
May 27, 2020 08:30AM
May 19, 2020 05:43AM Turning Point Therapeutics Inc. (TPTX) Prices 5.42M Share Common Offering at $60/Sh
May 18, 2020 08:52PM
May 18, 2020 08:51PM
May 18, 2020 07:04AM
May 18, 2020 07:00AM
May 18, 2020 07:00AM
Sep 6, 2019 05:45AM
Sep 5, 2019 08:34PM Turning Point Therapeutics Announces Pricing of Public Offering of Common Stock
Sep 5, 2019 08:34PM
Sep 3, 2019 04:14PM
Sep 3, 2019 04:14PM
Sep 3, 2019 04:14PM
Aug 6, 2019 04:05PM
Aug 6, 2019 04:05PM
Jul 29, 2019 08:32AM Turning Point Therapeutics Inc. (TPTX) Appoints Biotechnology Investment Banker Yi Larson as Executive Vice President and CFO
Jul 29, 2019 08:30AM
Jul 29, 2019 08:30AM
Jun 4, 2019 08:30AM
Jun 4, 2019 08:30AM
May 13, 2019 01:16AM
Apr 22, 2019 04:05PM
Apr 22, 2019 04:05PM Turning Point Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Apr 17, 2019 11:55AM
Apr 17, 2019 05:53AM
Apr 16, 2019 10:57PM

184,663 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All